---
$id: https://graph.org.ai/products/commodity/51343307
$type: Product
source: UNSPSC
code: "51343307"
title: "Rociclovir"
class: "51343300"
classTitle: "Antivirals, synthesized"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rociclovir

**UNSPSC Code**: 51343307
**Class**: [Antivirals, synthesized](Antivirals, synthesized.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DF29U51Y7. European Medicines Agency schedules Rociclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10351MIG. Rociclovir generally arises in the molecular formula C15H25N5O3. The term ROCICLOVIR is an International Non-Proprietary Name or INN. ROCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rociclovir under HS 29335995 and SITC 51576. As of Q4 2014, ROCICLOVIR remains the US FDA Preferred Term for this commodity. Rociclovir bears US NLM identifiers UMLS ID C0643822 and NCI Concept Code C73204. SMILES: O(C(COC(C)C)COC(C)C)CN1C2NC(NCC2NC1)N.

